Global organ preservation market value is estimated to reach US$ 455 Million by 2032, with a compound annual growth rate of 6.4%.
The process of preserving healthy organs from a donor so that they can be transplanted into the body of a recipient is called organ preservation. Static cold storage (SCS) aids in maintaining normal organ function after transplantation by preventing harmful metabolites from degrading healthy tissue.
Those suffering from terminal diseases are the most likely to benefit from organ transplantation. Preservation solutions and techniques are essential to preserving organ quality and preventing transplant-associated death and morbidity. In most cases, static cold storage (SCS) is considered to be the most efficient and effective method of preserving and transporting organs due to its simplicity and effectiveness.
Over the past few decades, solid organ transplants have been one of the most significant medical advancements. A wide variety of methods for preserving organs have been applied during cold storage to reduce ischemic and hypoxic injury and increase graft survival.
Since the advent of clinical organ transplants 50 years ago, patient and graft survival rates have surpassed 90% per year, resulting in organ transplantation becoming the treatment of choice for end-stage organ disease patients.
| Attributes | Details |
|---|---|
| Organ Preservation Market CAGR (2022 to 2032) | 6.4% |
| Organ Preservation Market (2026) | US$ 317 Million |
| Organ Preservation Market Attraction | A rising proportion of the geriatric population in North America and European countries will be the major driver for the growth of the global organ preservation market during the forecasted years. |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
With the largest population seeking better treatments, including organ transplantation preservation, the Asia Pacific region is expected to be the fastest-growing region as a whole in the industry. Asian countries are seeing an increase in awareness about organ donation, which has led to a rise in the market for organ preservation solutions.
Developing nations such as India and China are experiencing an increase in eye, cardiac, and kidney diseases. Technology advancement and emerging markets will offer profitable opportunities for the market. The government has also taken several initiatives to promote organ donation as part of its efforts to further expand the market growth. For instance,
Organ donation and transplantation are promoted by the Indian government through its National Organ Transplant Programme (NOTP). Several regional and state organ and tissue transplant organizations have been established under this initiative: one at the highest level in New Delhi, five at the regional level, and sixteen at the state level.
The National Organ Transplant Programme provides financial assistance to States for the establishment of Biomaterial Centers. Various IEC activities are being organized to raise public awareness and impart training to physicians and transplant coordinators to facilitate the acceptance of transplants.
With targeted radiotherapy and chemotherapy, medical professionals aim to preserve a surgically removed organ by preventing the particular cell from multiplying as a result of targeting radiotherapy and chemotherapy. As part of UICC's Access to Oncology Medicines (ATOM) initiative, multiple stakeholders were invited to the table to find ways of making cancer medicines more accessible and affordable especially in India.
An exciting development in health care has been the development of xenotransplantation - the ability to use a genetically modified organ from an animal to be used in humans after genetic modification. As gene editing techniques are developed and new knowledge is gained about the immunology of animals and its differences from the immune system of humans, it will probably continue to be a field that sees many advancements in the near future.
The geriatric population count is increasing day by day, leading to increased incidents of multi-organ failures and organ transplant surgeries worldwide. The requirement for efficient management of organ transfer from donors is driving the organ preservation market.
In 2019, the Health Resources and Services Administration reported about a rise in death cases due to multiple organ failures in the USA. The major treatment for such types of patients is organ replacement facilitated by human organ transplantation surgeries.
The organs obtained from donors require the appropriate handling and care achieved through the proper organ storage in cryogenic systems. The companies providing organic preservation solutions to hold and carry organs from donors to patients have experienced exponential growth these days.
Organ procurement and transplant network have expanded many folds making it easier for patients suffering from organ disorders. Organ preservation chemicals used for the storage of such organs obtained from companies dealing in the medical sector have benefitted immensely in recent years.
Principal Consultant
Healthcare and medical facilities in all countries were diverted towards the control of corona infection cases. The other medical services were abruptly halted, negatively impacting the organ preservation and transplantation market.
All the patients requiring the replacement of organs had to undergo rigorous Covid-19 testing and confirmation before getting admitted to any healthcare facility. Most of the skilled surgeons and healthcare professionals were also engaged in taking care of patients admitted with Covid-19 symptoms.
The problem in obtaining raw materials for the production of organ preservation solutions in the manufacturing units had some serious impact on the supply of preserved organs over long distances.
Restrictions on transportation and logistics were another major problem hampering the transport of human organs preserved for donation. In post-pandemic years demand for organ preservation and transplantation services increased due to the serious effects of the coronavirus on the internal organs of the body.
Diabetes and Chronic diseases have increased in frequency in the recent past resulting in severe medical conditions for multiple organ failures. Cardiovascular disorders and obesity have escalated the condition of patients to undertake the replacement of organs providing a huge impetus for the growth of the organ preservation market across the globe.
Solid-Organ transplant procedures have become more successful and safer in the 21st century owing to considerable advancement in surgical procedures and knowledge about the function of different organs.
But the healthcare sector is still struggling to meet the demands for organ transplantation due to the unavailability of sufficient organ donors or the limited supply of organ preservation fluids required to store and transport the organs already donated.
What are the Recent Developments Providing Better Opportunities for the Growth of the Organ Preservation Market?
Over the past years, there have been some major advancements in medical science, particularly in the field of organ preservation techniques and transplantation procedures, creating a huge demand for organ transplants in the global market. Coupled with the rising burden of diabetes patients, the demand for static cold storage organ preservation requirements during these years.
Encouragement for organ donations by various national and international NGOs has spurred the demand for organ preservation chemicals in the lesser-known regions of the world.
Improving health infrastructure across all countries has resulted in increased cases of patient termination in healthcare and medical facilities. The growing supply of organ preservation solutions in such major institutions has made it easier for the collection and preservation of human organs to be utilized by the organ preservation market.
What are Some of the Major Challenges faced by the Global Organ Preservation Market Players in Different Regions?
The development of cryogenic facilities for the maintenance of organ preservation fluid quality during transportation is a major challenge for the global organ preservation market, particularly in developing countries of the Asia Pacific and the Middle East and Africa (MEA).
The cost incurred during organ transplant surgeries and higher expenditure on inpatient care provided by healthcare facilities has remained the major constraint for the growth of the organ preservation and transplantation market. Patients in low-income countries require low-budget healthcare facilities to contribute more to the organ preservation market.
What are the Limitations in the Adoption of Organ Preservation Techniques in Recent Periods?
Availability of skilled personnel or surgery doctors at the healthcare centers is pride predicted to be the major challenge for the growth of the organ preservation and transplantation market during the forecast period at a higher scale.
Availability of suitable donors can be another major hindrance in the development of organ preservation techniques reducing the investment in research and advancement of organ preservation procedures by government institutions and private firms.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The most adopted technique is the static cold storage organ preservation method, commonly referred to as the gold standard technique of Organ preservation. This technique is very convenient to reduce metabolic activities and increase the self-life of the organs. This technique is popular for lung, heart, pancreas, and kidney preservation.
Hypothermia Machine Perfusion and Normothermic Machine Perfusion are some of the other techniques that need some research and technological advancements to compete with the static cold storage technique segment.
By the previous market analysis report, kidney preservation was the segment holding the largest share of the global organ preservation market. The escalating cases of ESRD with kidney transplantation have emerged as the major driver for this segment of the market and are predicted to be leading in the forthcoming years.
The other segment based on organ type having the highest potential of growth is liver preservation during the forecast period of 2022 to 2032. Lung, heart, and pancreas preservation are the other segments contributing to the growing trend of organ preservation.
By 2021, organ transplant centers were the dominating end users of the organ preservation market providing kidney preservation and liver preservation in different regions of the world. The better healthcare facilities and the increasing success rate has made it a popular choice for patients seeking organ replacement around the world. This segment is expected to remain at the forefront of organ preservation and transplantation during the forecast years.
Hospitals and other end users will also contribute significantly to the global organ preservation market, as per the report of the market analysis.
North America, comprising a higher proportion of the elder population and advanced Healthcare facilities, is poised to remain the most attractive region for organ storage and transplantation services.
The rising demand for technologically advanced treatment methods, government support, and reimbursements have fuelled the market for preserved human organs in recent times.
As per the report provided by the American Heart Association and National Chronic Kidney Disease Report, 31% of the total deaths in the USA occurred due to cardiovascular disorders in 2014 and in 2017, 15% of USA adults were subject to chronic kidney diseases.
Due to rising cases of alcoholic fatty liver diseases, Liver failures have positioned the Europe region as the second-largest market for organ preservation and transplantation, following North America. The healthcare expenditure in European countries has further fuelled the market for lever preservation for transplant facilities.
The prevalence of other serious diseases related to cardiovascular and renal will further supplement the demand for organ transplantation surgeries in this region.
Asia Pacific region is predicted to be the fastest-growing region for having the largest population count seeking better treatment methods, including organ transplantation preservation
services. The rising awareness about organ donations has boosted the organ preservation solution market in Asian countries.
Lack of awareness and affordability constraints for organ preservation techniques could render the Middle East and African countries the least attractive region for the global organ preservation market in the coming years.
The key players in the organ preservation driving the global market are XVIVO Perfusion AB, Dr. Franz Kohler Chemie GmbH, Essential Pharmaceuticals LLC, Trans Medics, Organ Ox Limited, Shanghai Genext Medical Technology, Bridge to Life Limited, Waters Medical Systems, Preservation Solutions, Carnamedica, and Transplant Biomedicals.
All the prominent players dealing in organ preservation have continually adopted the advancing technologies and have changed the course of organ preservation from the past to the future to provide the best service for patients in need.
In recent years they have been focusing on mergers and collaboration to expand the customer base in traditionally less popular regions.
Some of the Recent Developments in the Organ Preservation Market:
The global organ preservation market is predicted to register a CAGR of 6.4% during the forecast period.
The global organ preservation market was valued at US$ 230 Million in 2021.
The global organ preservation market is predicted to become a US$ 317 Million market by the year 2026.
The total market value of the organ preservation market is estimated to reach a value of about US$ 455 Million by the end of 2032.
North America is the dominant region that captured a major share of the global organ transplant preservation market and is predicted to remain in the leading position for some more years ahead.
1. Executive Summary | Organ Preservation Market
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. FMI Analysis and Recommendations
2. Market Overview
2.1. Market Coverage
2.2. Market Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Market
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Million)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Market, by Key Countries
4.2. Market Opportunity Assessment (US$ Million)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in Optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Market Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2015 to 2021 and Forecast, 2022 to 2032
6.1. Historical Market Analysis, 2015 to 2021
6.2. Current and Future Market Projections, 2022 to 2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2015 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$ Million) Analysis, 2015 to 2021
7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Solution
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Solution, 2015 to 2021
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Solution, 2022 to 2032
8.3.1. the University of Wisconsin Solution (UW Solution)
8.3.2. Custodial HTK
8.3.3. Perfadex
8.3.4. Other Solutions
8.4. Market Attractiveness Analysis By Solution
9. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Technique
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Technique, 2015 to 2021
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Technique, 2022 to 2032
9.3.1. Static Cold Storage
9.3.2. Hypothermic Machine Perfusion
9.3.3. Normothermic Machine Perfusion
9.4. Market Attractiveness Analysis By Technique
10. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Organ Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Organ Type, 2015 to 2021
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Organ Type, 2022 to 2032
10.3.1. Kidney
10.3.2. Liver
10.3.3. Lung
10.3.4. Heart
10.3.5. Pancreas
10.4. Market Attractiveness Analysis By Organ Type
11. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By End User, 2015 to 2021
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032
11.3.1. Organ Transplant Centers
11.3.2. Hospitals
11.3.3. Specialty Clinics
11.4. Market Attractiveness Analysis By End User
12. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Million) Analysis By Region, 2015 to 2021
12.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2022 to 2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
13.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
13.4.1. By Country
13.4.1.1. USA
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Solution
13.4.3. By Technique
13.4.4. By End User
13.4.5. By Organ Type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Solution
13.5.3. By Technique
13.5.4. By End User
13.5.5. By Organ Type
14. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
14.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Solution
14.4.3. By Technique
14.4.4. By End User
14.4.5. By Organ Type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Solution
14.5.3. By Technique
14.5.4. By End User
14.5.5. By Organ Type
15. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
15.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. United Kingdom
15.4.1.4. Italy
15.4.1.5. Benelux
15.4.1.6. Nordic Countries
15.4.1.7. Rest of Europe
15.4.2. By Solution
15.4.3. By Technique
15.4.4. By End User
15.4.5. By Organ Type
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Solution
15.5.3. By Technique
15.5.4. By End User
15.5.5. By Organ Type
16. Asia Pacific Market Analysis 2015 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
16.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. Rest of Asia Pacific
16.4.2. By Solution
16.4.3. By Technique
16.4.4. By End User
16.4.5. By Organ Type
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Solution
16.5.3. By Technique
16.5.4. By End User
16.5.5. By Organ Type
17. Middle East and Africa Market Analysis 2015 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
17.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. South Africa
17.4.1.3. Turkey
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Solution
17.4.3. By Technique
17.4.4. By End User
17.4.5. By Organ Type
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Solution
17.5.3. By Technique
17.5.4. By End User
17.5.5. By Organ Type
18. Key Countries Market Analysis 2015 to 2021 and Forecast 2022 to 2032
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. USA Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.2.2.1. By Solution
18.2.2.2. By Technique
18.2.2.3. By End User
18.2.2.4. By Organ Type
18.3. Canada Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.3.2.1. By Solution
18.3.2.2. By Technique
18.3.2.3. By End User
18.3.2.4. By Organ Type
18.4. Mexico Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.4.2.1. By Solution
18.4.2.2. By Technique
18.4.2.3. By End User
18.4.2.4. By Organ Type
18.5. Brazil Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.5.2.1. By Solution
18.5.2.2. By Technique
18.5.2.3. By End User
18.5.2.4. By Organ Type
18.6. Germany Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.6.2.1. By Solution
18.6.2.2. By Technique
18.6.2.3. By End User
18.6.2.4. By Organ Type
18.7. France Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.7.2.1. By Solution
18.7.2.2. By Technique
18.7.2.3. By End User
18.7.2.4. By Organ Type
18.8. Italy Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.8.2.1. By Solution
18.8.2.2. By Technique
18.8.2.3. By End User
18.8.2.4. By Organ Type
18.9. BENELUX Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.9.2.1. By Solution
18.9.2.2. By Technique
18.9.2.3. By End User
18.9.2.4. By Organ Type
18.10. United Kingdom Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.10.2.1. By Solution
18.10.2.2. By Technique
18.10.2.3. By End User
18.10.2.4. By Organ Type
18.11. Nordic Countries Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.11.2.1. By Solution
18.11.2.2. By Technique
18.11.2.3. By End User
18.11.2.4. By Organ Type
18.12. China Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.12.2.1. By Solution
18.12.2.2. By Technique
18.12.2.3. By End User
18.12.2.4. By Organ Type
18.13. Japan Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.13.2.1. By Solution
18.13.2.2. By Technique
18.13.2.3. By End User
18.13.2.4. By Organ Type
18.14. South Korea Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.14.2.1. By Solution
18.14.2.2. By Technique
18.14.2.3. By End User
18.14.2.4. By Organ Type
18.15. GCC Countries Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.15.2.1. By Solution
18.15.2.2. By Technique
18.15.2.3. By End User
18.15.2.4. By Organ Type
18.16. South Africa Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.16.2.1. By Solution
18.16.2.2. By Technique
18.16.2.3. By End User
18.16.2.4. By Organ Type
18.17. Turkey Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.17.2.1. By Solution
18.17.2.2. By Technique
18.17.2.3. By End User
18.17.2.4. By Organ Type
18.17.3. Competition Landscape and Player Concentration in the Country
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional Footprint of Players
19.4.2. Product Footprint by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Paragonix Technologies
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. XVIVO Perfusion AB
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. Dr. Franz Köhler Chemie GmbH
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. Essential Pharmaceuticals LLC
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. TransMedics
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. OrganOx Limited
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
20.3.7. Shanghai Genext Medical Technology
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Strategy Overview
20.3.8. Bridge to Life Limited
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Strategy Overview
20.3.9. Waters Medical Systems
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Strategy Overview
20.3.10. Preservation Solutions
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Strategy Overview
20.3.11. Carnamedica
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Sales Footprint
20.3.11.4. Strategy Overview
20.3.12. Transplant Biomedicals
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Sales Footprint
20.3.12.4. Strategy Overview
21. Assumptions and Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
Organ Preservation Market
